We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Regal Rexnord
RRX
$14.2B
| $876K | 0.02% |
14,720
| – | – |
|
|
RFP
602
DELISTED
Resolute Forest Products Inc.
RFP
| $875K | 0.02% |
184,922
-40,000
| -18% | -$218K |
|
603
TriCo Bancshares
TCBK
$1.85B
| $872K | 0.02% |
32,580
| – | – |
|
|
KG
604
Kestrel Group
KG
$71.3M
| $865K | 0.02% |
3,408
+950
| +39% | +$253K |
|
605
McCormick & Company Non-Voting
MKC
$13.4B
| $856K | 0.02% |
17,140
| – | – |
|
|
MEET
606
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $833K | 0.01% |
134,333
-133,500
| -50% | -$818K |
|
|
RST
607
DELISTED
ROSETTA STONE INC
RST
| $831K | 0.01% |
97,968
-6,700
| -6% | -$56K |
|
608
NiSource
NI
$22.4B
| $828K | 0.01% |
+34,330
| New | +$859K |
|
609
Piper Sandler
PIPR
$5.14B
| $828K | 0.01% |
68,600
-59,256
| -46% | -$645K |
|
610
Delek US
DK
$3.87B
| $821K | 0.01% |
47,480
| – | – |
|
611
Perdoceo Education
PRDO
$1.9B
| $821K | 0.01% |
120,980
+48,693
| +67% | +$331K |
|
612
Regis Corp
RGS
$69.9M
| $821K | 0.01% |
3,270
+1,145
| +54% | +$300K |
|
|
COHR
613
DELISTED
Coherent Inc
COHR
| $818K | 0.01% |
7,400
-390
| -5% | -$40.4K |
|
614
Employers Holdings
EIG
$908M
| $813K | 0.01% |
27,260
-8,400
| -24% | -$249K |
|
615
Madison Square Garden
MSGS
$9.54B
| $808K | 0.01% |
6,688
-1,135
| -15% | -$144K |
|
|
CCXI
616
DELISTED
ChemoCentryx, Inc.
CCXI
| $802K | 0.01% |
132,721
-17,600
| -12% | -$83.2K |
|
617
Acco Brands
ACCO
$369M
| $793K | 0.01% |
+82,284
| New | +$845K |
|
618
Hormel Foods
HRL
$13.9B
| $789K | 0.01% |
20,800
-590,280
| -97% | -$21.9M |
|
|
SFS
619
DELISTED
Smart & Final Stores, Inc.
SFS
| $787K | 0.01% |
+61,617
| New | +$853K |
|
|
HSII
620
DELISTED
Heidrick & Struggles
HSII
| $785K | 0.01% |
42,323
-4,200
| -9% | -$77.8K |
|
621
Quaker Houghton
KWR
$2.63B
| $781K | 0.01% |
7,373
-2,510
| -25% | -$245K |
|
622
Tetra Tech
TTEK
$8.23B
| $781K | 0.01% |
+110,050
| New | +$746K |
|
623
Central Pacific Financial
CPF
$997M
| $778K | 0.01% |
30,900
+5,300
| +21% | +$131K |
|
624
Cleveland-Cliffs
CLF
$6.81B
| $776K | 0.01% |
132,693
-36,000
| -21% | -$235K |
|
|
LVLT
625
DELISTED
Level 3 Communications Inc
LVLT
| $772K | 0.01% |
16,640
-26,821
| -62% | -$1.36M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.